Category: Mindray Medical International Ltd.
Ottoman Bay Research analysts claim they've finally found the "smoking gun" that proves their accusations that Mindray Medical isn't what it seems.
MASSDEVICE ON CALL — Analysts at short-seller Ottoman Bay Research, which have long held that Mindray Medical (NYSE:MR) management has misled investors, claim that they've found the so-called "smoking gun" that proves their accusations.
Short-seller Ottoman Bay Research issues another report accusing Mindray Medical's management of misleading investors.
Short-seller Ottoman Bay Research took another shot at Mindray Medical (NYSE:MR) this week, taking issue with the Chinese medical device company's response to Ottoman's initial accusations of fraud and mismanagement.
Shares of Mindray Medical, which lost 11% yesterday after a short seller issued a report alleging fraud, rebounded a bit today after the Chinese medtech company denied the accusations.
Chinese medical device maker Mindray Medical pays $15 million to settle a "commercial dispute" with Beckman Coulter.
China-based Mindray Medical lowered its full-year financial outlook on sluggish hospital purchases at home, even as sales and profits each gain 15% during the company's 3rd quarter.
Medical device companies including Cardinal Health and Mindray Medical are among the firms awarded contracts and extensions worth nearly $196 million by the U.S. Defense Dept.
The U.S. Defense Dept. awarded $195.8 million worth of contracts to 3 medical device firms.
CAZ Investments raises a $29 million round to back commercialized medical firms.
CAZ Investments raised a nearly $29 million funding round it plans to use to back medical companies that already have products on the market.
The Houston-based asset management firm reeled in $28.7 million from 61 unnamed investors, according to a regulatory filing.
CAZ Investments chairman Christopher Zook said the firm plans to use the cash to invest in commercialized companies.